Researchers start new investigation into Long COVID core outcome set
A group of researchers started this project with the aims of understanding what are the core outcomes for patients living with Long COVID.
Health
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
Two doses of Pfizer (PFE.N) or AstraZeneca’s (AZN.L) COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed.
Covid recovered with one/two doses of vaccine have higher protection against Coronavirus Delta variant: Study
Prior vaccination results in less severe disease against subsequent infection provide evidence that both humoral and cellular immune response play an important role in protection, according to the study
Rife COVID-19 variants fuel Africa’s surging wave
Brazzaville, 1 July 2021 – As COVID-19 case numbers in Africa climb faster than all earlier
India’s Covaxin effectively neutralises Delta variant of COVID-19, says NIH
The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the UK and India, respectively.
WHO certifies China malaria-free
China used to report 30 million cases of the disease annually in the 1940s.
WHO issues first global report on AI in health
Growing use of AI for health presents governments, providers, and communities with opportunities and challenges
Vaccine-linked heart condition tends to resolve quickly; Delta variant fuses cells to infect more efficiently
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
One in 100 deaths is by suicide: WHO
WHO guidance to help the world reach the target of reducing
suicide rate by one-third by 2030
Drug that blocks multiple coronavirus variants in mice identified
The findings, published in the journal Science Immunology, suggest that the drug diABZI activates the body’s innate immune response, the first line of defence against invading pathogens.